Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China
· Delayed Price · Currency is CNY 66.96
-0.65 (-0.96%)
At close: Dec 5, 2025
SHE:300255 Revenue
Hebei Changshan Biochemical Pharmaceutical had revenue of 189.61M CNY in the quarter ending September 30, 2025, a decrease of -12.32%. This brings the company's revenue in the last twelve months to 928.01M, down -12.02% year-over-year. In the year 2024, Hebei Changshan Biochemical Pharmaceutical had annual revenue of 1.03B, down -26.92%.
Revenue (ttm)
928.01M
Revenue Growth
-12.02%
P/S Ratio
66.31
Revenue / Employee
740.04K
Employees
1,254
Market Cap
61.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.03B | -379.63M | -26.92% |
| Dec 31, 2023 | 1.41B | -925.79M | -39.63% |
| Jan 1, 2023 | 2.34B | -631.82M | -21.29% |
| Jan 1, 2022 | 2.97B | 604.26M | 25.56% |
| Dec 31, 2020 | 2.36B | 292.31M | 14.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |